about
The role of estrogen and progesterone, administered alone and in combination, in modulating cytokine concentration following traumatic brain injury.Chronic Opium Treatment Can Differentially Induce Brain and Liver Cells Apoptosis in Diabetic and Non-diabetic Male and Female RatsAtorvastatin, Losartan and Captopril Lead to Upregulation of TGF-β, and Downregulation of IL-6 in Coronary Artery Disease and HypertensionPlasma Levels of IFN-γ, IL-4, IL-6 and IL-17 in HIV-Positive Patients With Oral Candidiasis.The association between urinary lgM excretion and diabetic retinopathy in diabetic patients.The anti-inflammatory properties of Satureja khuzistanica Jamzad essential oil attenuate the effects of traumatic brain injuries in ratsType 2 diabetes and mental disorders; a plausible link with inflammation.Implantation of fibre encapsulated RIN 1056a cells transfected with NPY cDNA into the lateral ventricle of rats alters body weight.Elevated levels of DNA methylation at the OPRM1 promoter region in men with opioid use disorder.In silico locating the immune-reactive segments of Lepidium draba peroxidase and designing a less immune-reactive enzyme derivative.The brain cytokine levels are modulated by estrogen following traumatic brain injury: Which estrogen receptor serves as modulator?Interferon-β 1a Modulates Expression of RAGE but Not S100A12 and Nuclear Factor-κB in Multiple Sclerosis Patients.The plasma levels of the cytokines in opium-addicts and the effects of opium on the cytokines secretion by their lymphocytes.Serum levels of IL-6, IL-10, IL-12, IL-17 and IFN-γ and their association with markers of bone metabolism in vitamin D-deficient female students.Genetic variation of IL-12B (+1188 region) is associated with its decreased circulating levels and susceptibility to Type 2 diabetesComparison of some salivary characteristics between children with and without early childhood cariesThe Effects of IFN-β 1a on the Expression of Inflammasomes and Apoptosis-Associated Speck-Like Proteins in Multiple Sclerosis Patients
P50
Q34156670-2D05D061-B5F7-4E9A-B4F4-28546689AF10Q35764822-AD1F2430-BD25-45A6-8FE1-1F0893F73464Q36235476-234A7EDA-0FE8-4235-95EA-D82D2487A5EBQ36828872-18540E41-EA21-4712-9473-D25B8EC5A84BQ37054807-A7D18ADE-3319-4A16-AE75-84773DC1A67DQ37184778-2CFF088B-34F5-4321-8F70-7B026FED3F3AQ39063577-861F1DF3-578E-4EE0-8134-8EADFF04AAABQ40366277-F927D684-FCB9-47D5-B7B9-E58EB3A3F51DQ44342878-7B41E744-8728-4B28-AD24-2FB1AD6AC248Q48029292-6C81FA9F-6DAC-4C9D-9CB1-663B8977EC6AQ48108672-E6432578-19E3-4F42-AD0F-ACA742627197Q50654281-7146619C-FA99-4249-9839-13D2F0AB9F74Q51057283-63D5A561-D9BD-4F5D-B370-1CA256CDFD67Q51316276-166A1277-35D0-481A-B2F3-7A2E3184F6D2Q83378864-E04B0D66-4007-465A-B096-A79D21DC3005Q86166711-DF832B43-E0AD-474F-938E-FDD508184567Q89094836-AC9394E2-0F81-4E01-B467-AE55837427E6
P50
description
researcher (ORCID 0000-0002-6417-5200)
@en
wetenschapper
@nl
name
Gholamreza R. Asadi Karam
@en
Gholamreza R. Asadi Karam
@nl
type
label
Gholamreza R. Asadi Karam
@en
Gholamreza R. Asadi Karam
@nl
altLabel
Asadi Karam GR
@en
prefLabel
Gholamreza R. Asadi Karam
@en
Gholamreza R. Asadi Karam
@nl
P31
P496
0000-0002-6417-5200